Patient sampling of capillary blood provides unique biological insights into autoimmune flares

In this webinar, ImYoo will present preliminary data on biological insights derived from their decentralized autoimmune flare study. Specifically, they will highlight cell-specific transcript markers identified through longitudinal sampling of flares in inflammatory bowel disease and rheumatoid arthritis – markers often overlooked in cross-sectional study designs. ImYoo will further explore how its decentralized approach to collecting substantial molecular data enhances patient diversity, compliance, and retention in studies.

Ideal for:

  • Discovery and Translational teams at Biopharma & Biotech companies
  • AI companies looking to use multiomic data to power target & drug discovery

What you will learn

  • Decentralized observational studies
  • Single-cell multiomic assays on small volumes of blood

Speakers

Tatyana Dobreva

Chief Executive Officer & Co-Founder, ImYoo

Tatyana originally started her career with hopes of becoming an astronaut, but a health crisis shifted her focus to biology. Diagnosed with Hashimoto’s thyroiditis, she was inspired by the crucial role of data in personalized medical treatment. At NASA’s Jet Propulsion Laboratory, she developed satellite radios, then pursued graduate studies at Caltech, exploring viral engineering and RNA sequencing. Tatyana co-founded ImYoo, leveraging molecular patient data to enhance biotech research. Her journey from aerospace engineering to biotech exemplifies her drive to integrate engineering solutions into health care, aiming to revolutionize medical diagnostics and treatment discovery.

Neil Spooner

Director Spooner Bioanalytical Solutions & Chair Patient Centric Sampling Interest Group

Neil is the Founder of Spooner Bioanalytical Solutions, helping companies to integrate biological fluid microsampling, and patient centric sampling and analysis into workflows. He also works with organizations to develop technologies and introduce them to the market. Neil also assists organizations with their understanding of emerging trends in the pharmaceutical industry and bioanalysis. Neil is a Senior Visiting Research Fellow at the University of Hertfordshire, Editor in Chief of the journal, Bioanalysis, Founder of the Patient Centric Sampling Interest Group and Co-Chair of the Reid Bioanalytical Forum. He has published over 70 peer reviewed manuscripts and delivered over 50 podium presentations.​​​​​​​

In association with